Literature DB >> 24101154

CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation.

Shuping Yang1, Lin Zhang, Miao Liu, Rong Chong, Shi-Jian Ding, Yuanhong Chen, Jixin Dong.   

Abstract

The Yes-associated protein, YAP, is a downstream effector of the Hippo pathway of cell-cycle control that plays important roles in tumorigenesis. Hippo-mediated phosphorylation YAP, mainly at S127, inactivates YAP function. In this study, we define a mechanism for positive regulation of YAP activity that is critical for its oncogenic function. Specifically, we found that YAP is phosphorylated in vitro and in vivo by the cell-cycle kinase CDK1 at T119, S289, and S367 during the G2-M phase of the cell cycle. We also found that ectopic expression of a phosphomimetic YAP mutant (YAP3D, harboring T119D/S289D/S367D) was sufficient to induce mitotic defects in immortalized epithelial cells, including centrosome amplification, multipolar spindles, and chromosome missegregation. Finally, we documented that mitotic phosphorylation of YAP was sufficient to promote cell migration and invasion in a manner essential for neoplastic cell transformation. In support of our findings, CDK1 inhibitors largely suppressed cell motility mediated by activated YAP-S127A but not the phosphomimetic mutant YAP3D. Collectively, our results reveal a previously unrecognized mechanism for controlling the activity of YAP that is crucial for its oncogenic function mediated by mitotic dysregulation. ©2013 AACR

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24101154      PMCID: PMC3861241          DOI: 10.1158/0008-5472.CAN-13-2049

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  53 in total

1.  Open mass spectrometry search algorithm.

Authors:  Lewis Y Geer; Sanford P Markey; Jeffrey A Kowalak; Lukas Wagner; Ming Xu; Dawn M Maynard; Xiaoyu Yang; Wenyao Shi; Stephen H Bryant
Journal:  J Proteome Res       Date:  2004 Sep-Oct       Impact factor: 4.466

2.  A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization.

Authors:  Yael Aylon; Dan Michael; Ayelet Shmueli; Norikazu Yabuta; Hiroshi Nojima; Moshe Oren
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

Review 3.  Hippo signaling in organ size control.

Authors:  Duojia Pan
Journal:  Genes Dev       Date:  2007-04-15       Impact factor: 11.361

Review 4.  Hippo signalling in the G2/M cell cycle phase: lessons learned from the yeast MEN and SIN pathways.

Authors:  Alexander Hergovich; Brian A Hemmings
Journal:  Semin Cell Dev Biol       Date:  2012-04-15       Impact factor: 7.727

5.  Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.

Authors:  Yi Liu-Chittenden; Bo Huang; Joong Sup Shim; Qian Chen; Se-Jin Lee; Robert A Anders; Jun O Liu; Duojia Pan
Journal:  Genes Dev       Date:  2012-06-07       Impact factor: 11.361

6.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.

Authors:  Dawang Zhou; Claudius Conrad; Fan Xia; Ji-Sun Park; Bernhard Payer; Yi Yin; Gregory Y Lauwers; Wolfgang Thasler; Jeannie T Lee; Joseph Avruch; Nabeel Bardeesy
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

7.  Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

Authors:  Jesper V Olsen; Michiel Vermeulen; Anna Santamaria; Chanchal Kumar; Martin L Miller; Lars J Jensen; Florian Gnad; Jürgen Cox; Thomas S Jensen; Erich A Nigg; Søren Brunak; Matthias Mann
Journal:  Sci Signal       Date:  2010-01-12       Impact factor: 8.192

8.  Cyclin-dependent kinase 1-mediated Bcl-xL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis.

Authors:  David T Terrano; Meenakshi Upreti; Timothy C Chambers
Journal:  Mol Cell Biol       Date:  2009-11-16       Impact factor: 4.272

9.  Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials.

Authors:  Shi-Jian Ding; Yan Li; Xiao-Xia Shao; Hu Zhou; Rong Zeng; Zhao-You Tang; Qi-Chang Xia
Journal:  Proteomics       Date:  2004-04       Impact factor: 3.984

Review 10.  A clinical overview of centrosome amplification in human cancers.

Authors:  Jason Yongsheng Chan
Journal:  Int J Biol Sci       Date:  2011-10-16       Impact factor: 6.580

View more
  50 in total

Review 1.  Drug development against the hippo pathway in mesothelioma.

Authors:  Gavitt A Woodard; Yi-Lin Yang; Liang You; David M Jablons
Journal:  Transl Lung Cancer Res       Date:  2017-06

2.  The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.

Authors:  Lin Zhang; Shuping Yang; Xingcheng Chen; Seth Stauffer; Fang Yu; Subodh M Lele; Kai Fu; Kaustubh Datta; Nicholas Palermo; Yuanhong Chen; Jixin Dong
Journal:  Mol Cell Biol       Date:  2015-02-02       Impact factor: 4.272

Review 3.  YAP/TAZ Signaling and Resistance to Cancer Therapy.

Authors:  Chan D K Nguyen; Chunling Yi
Journal:  Trends Cancer       Date:  2019-03-27

4.  Cyclin-dependent kinase 1 (CDK1)-mediated mitotic phosphorylation of the transcriptional co-repressor Vgll4 inhibits its tumor-suppressing activity.

Authors:  Yongji Zeng; Seth Stauffer; Jiuli Zhou; Xingcheng Chen; Yuanhong Chen; Jixin Dong
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

Review 5.  YAP and TAZ: a nexus for Hippo signaling and beyond.

Authors:  Carsten Gram Hansen; Toshiro Moroishi; Kun-Liang Guan
Journal:  Trends Cell Biol       Date:  2015-06-02       Impact factor: 20.808

6.  Polyomavirus small T antigen interacts with yes-associated protein to regulate cell survival and differentiation.

Authors:  Justin H Hwang; Arun T Pores Fernando; Nathalie Faure; Shaida Andrabi; Guillaume Adelmant; William C Hahn; Jarrod A Marto; Brian S Schaffhausen; Thomas M Roberts
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

Review 7.  The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.

Authors:  Manami Kodaka; Yutaka Hata
Journal:  Cell Mol Life Sci       Date:  2014-09-30       Impact factor: 9.261

8.  CDK1-mediated mitotic phosphorylation of PBK is involved in cytokinesis and inhibits its oncogenic activity.

Authors:  Seth Stauffer; Yongji Zeng; Jiuli Zhou; Xingcheng Chen; Yuanhong Chen; Jixin Dong
Journal:  Cell Signal       Date:  2017-08-03       Impact factor: 4.315

9.  Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP.

Authors:  Cecile Rouleau; Arun T Pores Fernando; Justin H Hwang; Nathalie Faure; Tao Jiang; Elizabeth A White; Thomas M Roberts; Brian S Schaffhausen
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

10.  MST2 phosphorylation at serine 385 in mitosis inhibits its tumor suppressing activity.

Authors:  Xingcheng Chen; Yuanhong Chen; Jixin Dong
Journal:  Cell Signal       Date:  2016-08-24       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.